Metagenomi, Inc Common Stock

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$3,911
$8,659
$8,513
$4,127
Gross Profit
2,611
7,335
-13,994
4,127
EBITDA
-23,067
-19,303
-19,652
-26,462
EBIT
-24,367
-20,627
-20,987
-27,820
Net Income
-22,528
-20,393
-19,908
-25,039
Net Change In Cash
3,911
8,659
8,513
4,127
Free Cash Flow
-23,631
-21,327
-21,378
-23,130
Cash
41,722
32,773
26,850
29,195
Basic Shares
37,620
37,349
37,156
37,019

Annual Financials

Values in thousands2025-09-302024-09-302023-09-302022-09-30
Revenue
$25,210
$52,295
$44,756
$17,200
Gross Profit
19,893
52,295
-49,647
15,467
EBITDA
-90,696
-83,494
-74,285
-39,193
EBIT
-96,013
-88,901
-78,492
-40,926
Net Income
-87,868
-78,058
-68,255
-43,593
Net Change In Cash
25,210
52,295
44,756
17,200
Free Cash Flow
-89,466
-112,187
-101,223
15,747
Cash
41,722
27,386
140,603
184,441
Basic Shares
37,251
37,418
37,472
37,472

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.60
2025-09-30
-$0.55
2025-06-30
-$0.54